AustraliaHealth

Aged care giant Regis Healthcare (ASX:REG) reported a sharp 45.1% decline in statutory net profit for the first half of FY26, falling to $13.4 million.

Mayne Pharma (ASX:MYX) reported revenue of $212.1 million for the first half of FY26, a marginal 0.5% decrease compared to the previous corresponding period.

Fisher & Paykel Healthcare (ASX:FPH) has upgraded its revenue and earnings guidance for the 2026 financial year ending March 31.

Telix Pharmaceuticals (ASX:TLX) reported a financial performance for the fiscal year ended Dec. 31, 2025, characterised by a 56% rise in total revenue to US$803.8 million.

Ramsay Health Care (ASX:RHC) announced a proposal to separate from its European subsidiary, Ramsay Santé.

Sonic Healthcare (ASX:SHL) announced its financial performance for the half-year ended Dec. 31, 2025, marked by double-digit revenue growth.

Medibank Group (ASX:MPL) reported a $297.8 million underlying net profit after tax for H1 FY26, a slight dip of 0.3%.

Telix Pharmaceuticals (ASX:TLX) submitted a Marketing Authorisation Application in Europe for its glioma imaging candidate, TLX101-Px.

Clinical-stage drug development company Nyrada (ASX:NYR) has released its half-year results for the 2026 fiscal year.

Mayne Pharma Group (ASX:MYX) has escalated its legal dispute with Cosette Pharmaceuticals, filing a substantial damages claim in the Supreme Court of New South Wales.

Biotech firm CSL (ASX:CSL) has entered into an exclusive licensing agreement with US pharmaceutical giant Eli Lilly and Company.

Healthcare giant Healius (ASX:HLS) saw H1 FY26 total revenue climb 3.8% to $688.1 million, driven largely by its core pathology division.